ScholarIQanswers from OpenAlex

Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection

PaperCitations, authors & open-access status

Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection have?

ScholarIQcitation count

Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection has 20 citations in the OpenAlex counts ScholarIQ stores.

When was Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection published?

ScholarIQyear

Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection has 2023 year in the ScholarIQ index.

What is the open-access status of Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection?

ScholarIQoa status

Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection has diamond oa status in the ScholarIQ index.

What is the DOI of Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection?

ScholarIQdoi

The DOI for Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection is on the source record.

What is the PMID of Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection?

ScholarIQpmid

The PMID for Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection is on the source record.

What is the OpenAlex record for Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection?

ScholarIQopenalex

The OpenAlex for Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial